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Suppl. 1 -S98 being measured postoperatively and that no seizures are being missed? The objectivity and accuracy of postoperative seizure recognition and reporting are susceptible to a large number of biases. For example, seizure phenomena may change postoperatively and may go unrecognized. Patients or caregivers may under-report because they do not want to disappoint the doctor (obsequiousness bias), because of strong preoperative expectations and beliefs (expectation bias), or because they feel compelled to justify the large psychological, physical or financial investment required by surgery (investment bias). At the opposite end of the spectrum are patients who depend on the sick role for emotional and financial support and who are likely to over-report seizures or to develop postoperative pseudoseizures. Clinicians are equally susceptible to expectation, obsequiousness, investment and other biases, depending on their role in individual patients'care. The unavoidable consequence of invalid seizure counts is a spuriously inflated or deflated therapeutic effect (depending on the prevailing biases), and the production of authoritarian rather than authoritative results. Validity is most threatened in retrospective, uncontrolled studies without systematic outcome assessment. It is least threatened in double blind RCTs where patients and clinicians remain truly blinded to treatment group. In the latter, inaccurate seizure measurement is distributed equally among treatment groups (the confounder is balanced).
The greatest potential for invalid seizure assessment and biased estimates of effectiveness occur with epilepsy surgery, where blinding is not possible, vested interests are high and no R C Ts exist. 1 2 , 1 3 A feasible solution is blinded external adjudication of events. This removes bias by submitting all new events to blinded assessment by experienced epileptologists. The procedure is being successfully utilized at the London Health Sciences Centre.
14 A conceivable minimum standard to improve validity in clinical practice would be to measure seizures systematically in all patients, eg., at similar intervals, with similar depth, and by similar personnel.
Reliability
Reliability refers to precision of measurement, i.e., the same result is obtained when measured at different times by different people. 15 Thus, are patients, care-givers and clinicians consistent in their reporting of postoperative events? This aspect of seizure measurement is largely determined by seizure knowledge and understanding. Unreliable seizure estimates increase measurement error, eg., increased "noise" in the "signal-to-noise" ratio, thereby decreasing precision and confidence of the measure. Research is sparse in this regard. Nonetheless, it is reassuring that in the two available studies, seizure reporting by patients and caregivers is consistent, both retrospectively and prospectively, within a one-day 16 or a two-month period. 17 Thus, the evidence indicates that, in practice, seizures seem to be reliably reported.
Counting seizures

Who should count?
The question of who should measure seizure outcome has to do with validity of reporting. Clinicians perceive that patients may report seizures with varying degrees of accuracy to diff e r e n t interviewers (personal communication: Drs. Parrent, Sahjpaul, Blume and Girvin). For example, they may under-report seizures to the treating neurosurgeon and neurologist (obsequiousness bias) and give more valid reports to more "neutral" personnel, such as nurses or research assistants. On the other hand, clinicians with a vested interest in surgical outcome may potentially introduce bias in reporting, eg., by choosing what and how they ask patients (framing bias). The degree and direction of bias inherent in who counts seizures remain empirical questions that require formal exploration. A d m i t t e d l y, in "real life" clinicians make therapeutic recommendations based on their impressions of seizure frequency and severity. However, if clinicians intend to use seizure counts to inform on effectiveness, validity may be strengthened by having "neutral" personnel count seizures in a standardized manner in all patients. Similarly, explicit description of methods will aid clinicians in interpreting the data.
How should we count? The seizure diar y
Surprisingly, little evidence exists regarding the validity of the most widely used method of measuring seizures, ie., the seizure diary. The usefulness of diaries has been assessed in a diversity of medical conditions and populations. Results vary by condition. For example, constipation, cough and smoke exposure are over-reported, daily activities are under-reported, and dietary intake, moderate alcohol use, menopausal symptoms and Parkinsonian symptoms are fairly accurately reported. Only two studies have analysed the validity of seizure diaries. Neugebauer et al 1 6 found a high correlation (0.95) between patients' prospective and retrospective seizure diaries for a single 24-hour period. Unfortunately, when seizure diaries are given repeatedly to measure the same time period, correlation may overestimate test-retest reliability because of learning effects and a high dependence on between-subject variability. 18 Also, patients may over-or under-report at highly consistent ratios and still show high correlation coefficients. The intra-class correlation coefficient deals with these problems and is the preferable method. 18 Glueckauf et al 17 have examined within-and betweensubject agreement in seizure diaries over consecutive 30-day periods. In patients with complex partial seizures, they looked at the consistency of retrospective and prospective seizure frequency reporting by patients and observers. Observers consistently under-reported retrospectively (by 50%) and prospectively (by 88%). The latter figure may be explained by observers being asked to report exclusively witnessed seizures, and not to rely on patient or third party accounts. High withinpatient retrospective and prospective consistency occurred. Because patients may not recall seizures that impair consciousness, such high levels of within-patient consistency were unexpected and replication of these findings would be reassuring. In practice, seizure diaries are often completed jointly by patient and caregiver. The reliability of this method has not been investigated. Similarly, it is important to evaluate validity of diaries for different seizure types and time frames, and to identify variables that affect validity.
What can be done to improve reliability and validity of seizure diaries? It has been claimed that in epilepsy, no method "no matter how compulsively collected, can ever be considered completely reliable". 11 This is true for all areas of clinical measurement, is not exclusive to epilepsy, and does not imply that improvement is unnecessary or untenable. T h e r e f o r e , clinicians must eschew nihilism. In clinical practice, patient and LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES Suppl. 1 -S99 caregiver education, review of recorded events and fostering patient motivation will likely result in increased reliability. 19 The importance of measuring in a systematic, standardized fashion cannot be overemphasized. In epilepsy surgery research, bias can be minimized by using surrogate masked seizure measuring methods, as described by Wiebe et al 14 in an RCT of temporal lobe epilepsy surgery. Alternative methods such as electronic patient reminders may be considered for research purposes. 20 If the magnitude and direction of systematic error in seizure diaries were known, correction factors could be used accordingly. This remains to be determined by methodological research.
That inroads are being made into validating existing measurement tools, indicates that methodological bridges can be built to improve estimates of surgical effectiveness in practice and research.
MAKING SENSE OF SEIZURE COUNTS
No amount of validity and reliability during seizure ascertainment will do for poorly presented or analysed data. This is not free of methodological problems and may explain why clinicians tolerate such meaningless seizure outcomes as "50% improvement in 50% of patients".
The issues surrounding analysis of seizure outcome have been long recognized. 21, 22 Problems encompass non-randomness of seizure occurrence (seizure clusters), 2 1 unpredictability of postoperative seizure patterns and change over time, eg., the running down phenomenon, 23 and incorporating measures of seizure severity.
Commonly used analyses
Seizure outcome has been presented in a variety of ways. Common report methods include gross categories (improved, unchanged, worse), percentage change in average seizure frequency over pre-established time periods, number of seizurefree days, the cumulative sum technique, categorical scales (outcome classifications), and time to discontinuation of drugs. In epilepsy surg e r y, the most frequent methods are percent change in seizure frequency and allocation of patients into various outcome classifications, among which Engel's is the commonest. 
Seizure frequency
Percent change in seizure frequency is typically calculated as [(seizures after/seizures before)-1] x 100. The main problem with this approach is its asymmetry. That is, improvement has an upper limit of 100% (seizures totally controlled), but no limit exists for seizure worsening. Consequently, a few patients with seizure worsening would bias the estimates of effectiveness against the treatment under scrutiny. Leppik et al 25 suggest a "truncated" seizure worsening with a maximum of 100% to account for asymmetries. This is useful as long as worsening does not exceed 100%. However, the amount of information lost and the potential for bias are readily apparent. Some AED trials use a "symmetrized response ratio" where worsening can never reach 100%. This is obtained by [(seizures after -seizures before)/(seizures after + seizures before)] x 100. Unfortunately, this calculation considerably biases results in favour of improvement. For example, if a patient with 4 seizures/month improves to 1 seizure/month (decrease by 3/month), this would represent 60% improvement. If the same subject worsened by the same number of seizures (3/month) to 7 seizures/month this would represent only 27% worsening. Even a tenfold increase (eg., from 4 to 40) represents only 82% worsening. Unfortunately, no available seizure frequency method deals with asymmetry or non-random (cluster) seizure occurrence.
Survival analysis
A viable alternative may be survival analysis, a technique that measures the proportion of patients reaching an outcome of interest over time. The method is attractive because it accounts for staggered patient recruitment and variation in length of follow-up. Results are presented graphically as survival curves which can be compared for various interventions or patient groups. Time to seizure recurrence has been advocated by some as the most relevant outcome in surgical and medical trials. 26 It has been used in an RCTcomparing amygdalohippocampectomy versus anterior temporal lobectomy, 27 in studies of seizure recurrence after a first unprovoked seizure, 2 8 p o p u l a t i o n studies, 12 and RCTs of discontinuation of AEDs. 29, 30 Variations of survival analysis techniques include proportion of patients achieving seizure-free periods of pre-established duration, eg., one or two years, 31, 32 and time to the 'nth' seizure. Based on a proposal by Shofer and Temkin, 22 Eslava Cobos 33 advocates time to the 'kth'seizure as a patient-centred measure of improvement that is readily applicable to a wide range of seizure frequencies. Bourgeois et al 34 applied this analysis to measure time to fourth seizure in an AED trial. A feature of this technique is that in contrast to seizure frequency analysis, its power to detect between treatment differences remains stable through a wide range of baseline seizure frequencies. On the other hand, power is lower than with seizure frequency methods, therefore requiring larger sample sizes. It can be readily appreciated that with this type of survival analysis the endpoint seizure number ' k ' is chosen arbitrarily. On the other hand, the endpoint commonly used in RCTs of AEDs, ie., 50% improvement in 50% of patients, is not only arbitrary but also clinically meaningless. Therefore, if clinically relevant 'ks' could be agreed upon for various seizure types and frequencies, time to 'kth'seizure might be a reasonable option. This remains an empirical question. Finally, completeness of follow-up and avoidance of crossovers are crucial for meaningful survival analyses.
Composite indices
A composite index that incorporates seizure frequency and severity and treatment side-effects would be very useful. Such an index was developed by Cramer et al, 35 used in the VA study of AED monotherapy, 3 6 and further validated. 3 7 H o w e v e r, the index's cumbersomeness has prevented widespread use. The development of simpler indexes remains a worthwhile research endeavour.
MEASURING SEIZURE SEVERITY
Clinicians often encounter patients whose response to medical and surgical therapy is a change in seizure "intensity" with or without concurrent change in seizure frequency. The relevance of seizure intensity or severity makes sense clinically. Patients may be affected by gaining a warning so they can take precautions, or by recovering faster, having less disruptive automatisms and experiencing no falls or injuries. Accordingly, THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
Suppl. 1 -S 100
Smith et al 38 have found that after correcting for psychosocial factors, seizure severity is an independent and stronger determinant of HRQOL than seizure frequency. T h e r e f o r e , seizure severity should be incorporated when measuring seizure outcomes.
Seizure severity scales
In adults, two philosophical approaches to assess seizure severity have yielded two different instruments:
The Liverpool Seizure Severity Scale (Appendix A)
This attempts to capture the patient's perception of seizure severity. It is a self-administered 20-item instrument divided into two 10-item sections, one (termed "ictal") measuring ictalpostictal phenomena and one (termed "percept") measuring predictability or control of seizures. 39 The reliability, crosssectional validity and responsiveness of the scale, particularly the "ictal" subscale, have been demonstrated. 39 The National Hospital Seizure Severity (Chalfont) Scale
This group considered patient-centred assessment of seizure severity to be too "subjective" and designed an "objective," physician-centred scale of seizure severity. 40 The most recent, 7-item version is completed by the clinician with the assistance of a witness. It has demonstrated reliability and validity, and its responsiveness is being tested. 41 Their developers point out that although patient-centred health status measures (eg., quality of life) are important, seizure severity is better assessed by external observers than by the patients. Both measures have adequate measurement properties, but head-to-head comparisons are necessary to determine their relative usefulness.
Seizure severity in children
In children, parents'assessment of seizure severity by means of the Hague seizure severity scale (HASS) has been shown to correlate with other severity measures and to be a better indicator than physician assessment of severity. 42 The usefulness of this instrument in clinical studies remains to be determined.
A word of caution
It is strongly recommended that clinicians use previously validated scales to assess seizure severity, unless compelling reasons exist not to do so. Equally important is that scales are used as per developers' instructions. A mere "distaste" for existing validated instruments should be tempered by the fact that using non-validated questionnaires concocted on the spot, yields irreproducible results whose interpretation is difficult or impossible. If crucial elements are felt to be missing from existing scales, the alternative is to design and validate a new instrument, which is no small job, or to use additional valid instruments that tap into the domains of interest.
THE CANADIAN PERSPECTIVE
In an era of increasing demands for evidence to support practice, clinicians involved in epilepsy surgery face the challenge of providing scientifically sound data on the benefits and risks of these interventions. The many biases and threats to validity that befall epilepsy surgery (and the published evidence) leave much room for concern. This requires rethinking of the methods used to measure outcome with emphasis on developing scientifically rigorous standards. Ideally, these standards should be conceptualized and implemented at an international level. This faces the formidable hurdles of differences in practice patterns, health care systems, and cultural and philosophical viewpoints.
Because of their many commonalities (eg., health care system, practice patterns, ideology), Canadian epilepsy clinics and surgical centres are a step closer to developing such a concerted effort. Canadian national workshops such as this serve as platforms for exchanging ideas, identifying practice patterns and improving methodology. For example, during this workshop, it was recognised that standard measurements would apply not only to RCTs but also to prospective studies and descriptive case series. In this manner, standardization of prospective measurement for specific questions across centres could provide much needed information about prognosis and risk factors in a relatively short period of time. Specific endeavours, including standardized, systematic seizure measurement and data gathering, integration into a national database 4 3 a n d consideration of a core set of instruments are no longer utopian goals but actual ongoing efforts. It is conceivable that the Canadian Epilepsy Database and Registry (CEDaR) 43 could incorporate specific seizure severity scales and perform analyses of seizure measurement methods using its large cohort of epilepsy clinic patients. Similarly, the Canadian Epilepsy Consortium (CEC) could make recommendations to the pharmaceutical industry regarding seizure measurement in drug trials. Jointly, national organizations such as CEC, Canadian League Against Epilepsy and Epilepsy Canada, could suggest a "core" set of standardized measures to which clinicians and researchers could add as their particular hypothesis required. The set core would serve as a "reference case" for purposes of comparison (and data pooling) across studies. This approach has been successfully assembled for economic evaluations in the US Public Health Service. 44 Finally, collaborative research efforts with robust methodology would go a long way towards increasing our understanding of the surgical treatment of epilepsy.
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PERCEPT SUBSCALE
